Wachovia downgrades Amgen (Nasdaq: AMGN) from Outperform to Market Perform with a $37-$41 valuation range.

The firm said it ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE